How Much Did Ada Health Raise? Funding & Key Investors

Date
April 14, 2025
Ada Health

Total amount raised

$189.5 Millions

Latest funding date

02/01/2022

Ada Health

Location

Title

LINKEDIN

Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Ada Health has successfully raised funds through multiple rounds, with the latest being a Series B round closed on February 10, 2022. The company is backed by 13 investors, including Bertelsmann and Red River West.

Keep reading to explore the intricacies of Ada Health's fundraising journey and the investors backing this innovative platform.

What Is Ada Health?

Ada Health, founded in 2011, is a digital health company based in Berlin, Germany. The company was established by Claire Novorol, Daniel Nathrath, and Martin Hirsch.

Specializing in AI-powered symptom assessment, Ada Health offers a mobile application that helps diagnose symptoms and provides treatment advice. The platform is optimized by clinicians and supported by a comprehensive Medical Library.

With a workforce of 251-500 employees, Ada Health continues to innovate in the healthcare sector, providing tools for both individual users and organizations to improve health outcomes.

How Much Funding Has Ada Health Raised?

  1. Angel Round
    • Amount Raised: $20M
    • Date: October 2011
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To kickstart the development of Ada Health's AI-powered symptom assessment platform.
  2. Grant
    • Amount Raised: €2.4M
    • Date: July 2015
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To support early-stage research and development efforts.
  3. Series A
    • Amount Raised: €40M
    • Date: October 2017
    • Lead Investors: Vitruvian Partners
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To expand the platform's capabilities and scale operations.
  4. Series B
    • Amount Raised: €74M
    • Date: May 2021
    • Lead Investors: Leaps by Bayer
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To enhance the platform's AI capabilities and expand into new markets.
  5. Series B
    • Amount Raised: $30M
    • Date: February 2022
    • Lead Investors: Farallon Capital, Red River West, Bertelsmann Investments
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To develop enterprise solutions and strengthen market presence in the USA.

Total Amount Raised: $30M + €116.4M

Current Valuation: Not publicly disclosed

Key Investors

  • Bertelsmann
    • Details: Bertelsmann is a global media, services, and education company. It operates in about 50 countries and employs around 130,000 people.
    • Investment Focus Areas: Media, services, education, digital businesses.
    • Notable Investments: Penguin Random House, RTL Group, Arvato.
  • Red River West
    • Details: Red River West is a venture capital firm that supports European tech companies in their expansion to the US market. The firm is known for its strategic investments in technology and digital transformation.
    • Investment Focus Areas: Technology, digital transformation.
    • Notable Investments: Not specified.
  • Leaps by Bayer
    • Details: Leaps by Bayer is the venture capital arm of Bayer, focusing on breakthrough innovations in life sciences. The firm aims to address some of the world's biggest challenges in health and agriculture.
    • Investment Focus Areas: Life sciences, breakthrough innovations.
    • Notable Investments: Not specified.
  • Samsung Catalyst Fund
    • Details: Samsung Catalyst Fund is the venture capital arm of Samsung, investing in disruptive technologies and business models. The fund supports startups that align with Samsung's strategic interests.
    • Investment Focus Areas: Disruptive technologies, business models.
    • Notable Investments: Not specified.
  • Vitruvian Partners
    • Details: Vitruvian Partners is a European private equity firm that invests in high-growth companies. The firm focuses on dynamic situations characterized by rapid growth and change.
    • Investment Focus Areas: High-growth companies.
    • Notable Investments: Not specified.

What's Next for Ada Health?

The future looks promising for Ada Health as it focuses on developing enterprise solutions and strengthening its market presence in the USA. With a recent $30 million investment, the company is well-positioned to capitalize on the growing interest in digital health and personalized healthcare solutions.

Given the significant backing from high-profile investors, Ada Health is likely to attract further funding to expand its technological capabilities and market reach. However, the company may face challenges such as competition from other digital health startups and regulatory hurdles in different markets, especially in the USA.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Ada Health and gather other critical business insights.

Sign up for free and start exploring the wealth of information available at Clay.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

Try for free

More Articles